Medicare billing address
CMS Medicare provider billing file
3000 Mack RdSuite 120
Fairfield, OH 45014
CMS public data · NPI 1083674220
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Gregory Colangelo, M.D.
Specialty
Credential
M.D.
NPI
1083674220
Primary source state
OH
Data retrieval date
July 26, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Gregory Colangelo, M.D. from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
3000 Mack RdCMS Doctors & Clinicians file
3000 Mack RdIn the 2024 CMS provider billing file, this NPI had 427 Medicare beneficiaries and 935 total services. The average beneficiary age was 75, and the average HCC risk score was 2.
Total Medicare allowed amount
$84,420.24
Total Medicare payment amount
$60,960.76
Medicare beneficiaries
427
Total services
935
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hyperlipidemia
75%
CMS beneficiary-panel share
Hypertension
75%
CMS beneficiary-panel share
COPD
70%
CMS beneficiary-panel share
Ischemic heart disease
51%
CMS beneficiary-panel share
Heart failure
41%
CMS beneficiary-panel share
Chronic kidney disease
35%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 468 | $118.52 |
| Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 121 | $85.22 |
| Test to determine lung volumes using sensors | 50 | $11.03 |
| Test to examine how well the lungs exchange gases | 50 | $8.19 |
| New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more | 39 | $158.04 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 37 | $9.41 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 31 | $71.12 |
| Test to measure expiratory airflow and volume | 16 | $7.69 |
| Administration of influenza virus vaccine | 15 | $28.40 |
| Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) | 15 | $26.29 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1083674220. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Albuterol Sulfate Hfa | Albuterol Sulfate | 703 | 852.6 | $16,226.12 |
| 2 | Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 659 | 875 | $554,693.81 |
| 3 | Prednisone | Prednisone | 355 | 372.3 | $1,013.54 |
| 4 | Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 256 | 336 | $205,979.90 |
| 5 | Azithromycin | Azithromycin | 214 | 294.6 | $1,745.75 |
| 6 | Breo Ellipta | Fluticasone/Vilanterol | 188 | 272 | $106,245.32 |
| 7 | Montelukast Sodium | Montelukast Sodium | 163 | 370 | $1,494.47 |
| 8 | Doxycycline Hyclate | Doxycycline Hyclate | 151 | 154.8 | $1,330.69 |
| 9 | Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 135 | 169 | $78,022.56 |
| 10 | Symbicort | Budesonide/Formoterol Fumarate | 124 | 188 | $42,594.71 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Medical school
University Of Cincinnati College Of Medicine
Graduation year
1985
Group/practice field
Mercy Health Physicians Cincinnati Specialty Care Llc
Telehealth reported
Not reported
Secondary specialty fields reported by CMS: Internal Medicine.
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.